Dr. Noujan Adl-Tabatabai, MD

Dr. Adl-Tabatabai practices at Adventist Health Glendale in Glendale, California, part of Adventist Health.

Dr. Adl-Tabatabai's NPI, 1174693352, was assigned on November 8, 2006. Dr. Adl-Tabatabai graduated from Albert Einstein College of Medicine in 2000. Dr. Adl-Tabatabai's California license number on file is A101867.

Dr. Adl-Tabatabai's primary practice is Adventist Health Glendale, at 1509 E Wilson Terrace, Glendale, CA 91206 in Los Angeles County. The practice phone is (818) 409-8202.

Dr. Adl-Tabatabai's primary practice is Adventist Health Glendale in Glendale, California, part of Adventist Health. The medical group on file is Glendale Adventist Emergency Physicians. Dmand AI also links Dr. Adl-Tabatabai to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Adl-Tabatabai practices. Vendor and product names are available with a free account.

Emergency medicine is Dr. Adl-Tabatabai's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Adl-Tabatabai is board certified in emergency medicine by the American Board of Emergency Medicine. Dmand AI has Dr. Adl-Tabatabai's licenses on file in 2 states: California and New York.

CMS data shows 805 Medicare services from Dr. Adl-Tabatabai across 4 procedure codes in 2024, for 763 Medicare patients. Medicare paid $98,670 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 763 Medicare patients who saw Dr. Adl-Tabatabai in 2024. The largest group is 65 to 74, with 255 patients. 75% of them have arthritis, and 75% have high blood pressure. 82% are also on Medicaid. Their average risk score is 2.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Adl-Tabatabai's median patient age at 47, with 56% women.

In 2024, Dr. Adl-Tabatabai wrote 319 Medicare Part D claims for 196 patients. 96% of them were for generic drugs. CMS names the drug for 230 of them, across 8 drugs with 11 or more claims each, at $1,100 in total drug cost. In 2023, CMS named 159 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Adl-Tabatabai for performance year 2024, reported as part of a group. Dr. Adl-Tabatabai accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 24 general payments to Dr. Adl-Tabatabai from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $134.

Dr. Adl-Tabatabai graduated from Albert Einstein College of Medicine in 2000.

Dr. Adl-Tabatabai is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.